NeoFOL-R Trial (Perioperative Versus Adjuvnat FOLFIRINOX in Resectable Pancreatic Cancer) — StellaPhase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations(2 sites)
South Korea
Department of Internal Medicine, Seoul St. Mary's Hospital, Catholic University College of Medicine, Seoul Department of Surgery, Seoul National University College of Medicine, Seoul Age range
19 Years – 80 Years
Last updated November 2024